Swedish BioArctic takes step towards at-home Alzheimer’s treatment in China
Swedish biopharma company BioArctic said its partner Eisai has filed a subcutaneous version of Leqembi in China. The application was accepted by China’s National Medical Products Administration. BioArctic said the …
Swedish BioArctic takes step towards at-home Alzheimer’s treatment in China Read More